Tzyh-Mann Wei

This inventor holds 8 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Chirogate International Inc.. Active years: 2022-2025.

USPTO Granted Patents = 8 (Patent Applications = 1)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

8 out of 30

Chirogate International Inc.

patents

Years Active: 2022-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12497375 - Processes and intermediates for the preparations of benzoprostacyclin analogues and benzoprostacyclin analogues prepared therefrom (2025-12-16),

2. 12497374 - Processes and intermediates for the preparations of benzoprostacyclin analogues and benzoprostacyclin analogues prepared therefrom (2025-12-16),

3. 12428361 - Processes and intermediates for the preparation of carbaprostacyclin analogues (2025-09-30),

4. 12221411 - Processes and intermediates for the preparation of carbaprostacyclin analogues (2025-02-11),

5. 11884640 - Processes and intermediates for the preparations of benzoprostacyclin analogues and benzoprostacyclin analogues prepared therefrom (2024-01-30),

6. 11884613 - Processes and intermediates for the preparation of carbaprostacyclin analogues (2024-01-30),

7. 11339110 - Efficient crystallization process for preparing ultrapure Treprostinil and crystal prepared therefrom (2022-05-24),

8. 11332433 - Process for the preparation of latanoprostene bunod and intermediate thereof and compositions comprising the same (2022-05-17),

Title: The Innovative Journey of Tzyh-Mann Wei

Introduction

Tzyh-Mann Wei is a prominent inventor based in Yangmei, Taiwan. With a total of five patents to his name, he has made significant contributions to the field of pharmaceutical and chemical processes. His work showcases the innovative spirit necessary for advancements in medicinal chemistry.

Latest Patents

Tzyh-Mann Wei's latest patents include significant advancements in the preparation of carbaprostacyclin analogues. This invention relates to unique processes for creating these analogues and the intermediates derived from these processes. Additionally, he has also developed processes and intermediates for the creation of benzoprostacyclin analogues. Both inventions involve cyclopentenone intermediates, which can be in either racemic or optically active forms, further emphasizing the versatility and potential applications of his work.

Career Highlights

Currently, Tzyh-Mann Wei is associated with Chirogate International Inc., a company dedicated to innovative solutions in chemistry and pharmaceuticals. His career reflects a commitment to research and development, contributing to the creation of more effective medicinal compounds through his inventive processes.

Collaborations

Throughout his career, Tzyh-Mann Wei has worked alongside esteemed colleagues such as Shih-Yi Wei and Chun-Yu Lin. These collaborations have enriched his research endeavors, bringing together diverse expertise to enhance innovation in their respective fields.

Conclusion

Tzyh-Mann Wei's pioneering efforts and documented patents demonstrate his impactful role in advancing pharmaceutical innovations. As he continues to work with Chirogate International Inc. and his collaborators, the contributions of Tzyh-Mann Wei are likely to lead to further breakthroughs in medicinal chemistry and related areas.